Rupatadine Protects against Pulmonary Fibrosis by Attenuating PAF-Mediated Senescence in Rodents

PLoS ONE - Tập 8 Số 7 - Trang e68631
Xiaoxi Lv1, Xiaoxing Wang1, Ke Li1, Ziyan Wang1, Zhe Li1, Qi Lv1, Xiaoming Fu1, Zhuowei Hu1
1Molecular Immunology and Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P R China.

Tóm tắt

Từ khóa


Tài liệu tham khảo

TA Wynn, 2011, Integrating mechanisms of pulmonary fibrosis, J Exp Med, 208, 1339, 10.1084/jem.20110551

PW Noble, 2012, Pulmonary fibrosis: Patterns and perpetrators, J Clin Invest, 122, 2756, 10.1172/JCI60323

RM du Bois, 2010, Strategies for treating idiopathic pulmonary fibrosis, Nat Rev Drug Discov, 9, 129, 10.1038/nrd2958

IE Fernandez, 2012, New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis, Lancet, 380, 680, 10.1016/S0140-6736(12)61144-1

HZ Yang, 2009, Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment, J Immunol, 182, 692, 10.4049/jimmunol.182.1.692

N Kikuchi, 2010, Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and th1/th2 balance, Respir Res, 11, 31, 10.1186/1465-9921-11-31

S Mi, 2011, Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms, J Immunol, 187, 3003, 10.4049/jimmunol.1004081

I Kotsianidis, 2009, Global impairment of CD4+ CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 179, 1121, 10.1164/rccm.200812-1936OC

LM de Mello, 2009, Th1/Th2 balance in concomitant immediate and delayed-type hypersensitivity diseases, Immunol Lett, 124, 88, 10.1016/j.imlet.2009.04.011

CL Sokol, 2008, A mechanism for the initiation of allergen-induced T helper type 2 responses, Nat Immunol, 9, 310, 10.1038/ni1558

YH Wang, 2008, The IL-17 cytokine family and their role in allergic inflammation, Curr Opin Immunol, 20, 697, 10.1016/j.coi.2008.09.004

SA Summers, 2012, Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction, Kidney Int, 82, 676, 10.1038/ki.2012.211

T Kohyama, 2010, Histamine stimulates human lung fibroblast migration, Mol Cell Biochem, 337, 77, 10.1007/s11010-009-0287-y

ST Holgate, 2003, Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling, J Allergy Clin Immunol, 111, S18, 10.1067/mai.2003.25

YD Lang, 2010, Chymase mediates paraquat-induced collagen production in human lung fibroblasts, Toxicol Lett, 193, 19, 10.1016/j.toxlet.2009.12.001

M Metz, 2011, Rupatadine for the treatment of allergic rhinitis and urticaria, Expert Rev Clin Immunol, 7, 15, 10.1586/eci.10.85

C Picado, 2006, Rupatadine: Pharmacological profile and its use in the treatment of allergic disorders, Expert Opin Pharmacother, 7, 1989, 10.1517/14656566.7.14.1989

RC De Lisle, 2009, Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse, PLOS ONE, 4, e4283, 10.1371/journal.pone.0004283

GK Reddy, 1996, A simplified method for the analysis of hydroxyproline in biological tissues, Clin Biochem, 29, 225, 10.1016/0009-9120(96)00003-6

EF Redente, 2010, Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation, J Leukoc Biol, 88, 159, 10.1189/jlb.0609378

JE Phillips, 2012, Bleomycin induced lung fibrosis increases work of breathing in the mouse, Pulm Pharmacol Ther, 25, 281, 10.1016/j.pupt.2011.10.001

E Lim, 2011, Monitoring tumor metastases and osteolytic lesions with bioluminescence and micro CT imaging, J Vis Exp, e2775

B Hinz, 2007, The myofibroblast: One function, multiple origins, Am J Pathol, 170, 1807, 10.2353/ajpath.2007.070112

JP Thiery, 2006, Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038/nrm1835

NJ Carter, 2011, Pirfenidone: In idiopathic pulmonary fibrosis, Drugs, 71, 1721, 10.2165/11207710-000000000-00000

M Vasiadi, 2010, Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli, Int Arc Allergy Immunol, 151, 38, 10.1159/000232569

HP McNeil, 2008, The mouse mast cell–restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis, Arthritis Rheum, 58, 2338, 10.1002/art.23639

S Prokop, 2011, M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis, Am J Pathol, 178, 1279, 10.1016/j.ajpath.2010.11.065

MR Andrade, 2012, Pathogenic mycobacterium bovis strains differ in their ability to modulate the proinflammatory activation phenotype of macrophages, BMC Microbiol, 12, 166, 10.1186/1471-2180-12-166

J Gauldie, 2007, TGF-beta, Smad3 and the process of progressive fibrosis, Biochem Soc Trans, 035, 661, 10.1042/BST0350661

P Shivshankar, 2012, Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice, Am J Respir Cell Mol Biol, 47, 28, 10.1165/rcmb.2011-0349OC

JC Acosta, 2008, Chemokine signaling via the CXCR2 receptor reinforces senescence, Cell, 133, 1006, 10.1016/j.cell.2008.03.038

DC Rubinsztein, 2011, Autophagy and aging, Cell, 146, 682, 10.1016/j.cell.2011.07.030

H Lin, 2012, Autophagic flux, supported by toll-like receptor 2 activity, defends against the carcinogenesis of hepatocellular carcinoma. 12:1859-61

JP Coppé, 2010, The senescence-associated secretory phenotype: The dark side of tumor suppression, Annu Rev Pathol, 5, 99, 10.1146/annurev-pathol-121808-102144

P Soroosh, 2009, Th9 and allergic disease, Immunology, 127, 450, 10.1111/j.1365-2567.2009.03114.x

C Malmhäll, 2012, Immunophenotyping of circulating T helper cells argues for multiple functions and plasticity of T cells in vivo in humans--possible role in asthma, PLOS ONE, 7, e40012, 10.1371/journal.pone.0040012

SN Giri, 1986, Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters, Toxicol Pathol, 14, 149, 10.1177/019262338601400202

T Okamoto, 2009, Histamine H1-receptor antagonists with immunomodulating activities: Potential use for modulating T helper type1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases, Clin Exp Immunol, 157, 27, 10.1111/j.1365-2249.2009.03958.x

SN Giri, 1995, Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters, Exp Lung Res, 21, 287, 10.3109/01902149509068833

F Rodier, 2011, Four faces of cellular senescence, J Cell Biol, 192, 547, 10.1083/jcb.201009094

V Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell, 134, 657, 10.1016/j.cell.2008.06.049

T Tsuji, 2010, Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease, Respiration, 80, 59, 10.1159/000268287

A Linge, 2007, Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells, Int J Biochem Cell Biol, 39, 1964, 10.1016/j.biocel.2007.05.018

AV Orjalo, 2009, Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network, Proc Natl Acad Sci U S A, 106, 17031, 10.1073/pnas.0905299106

B Levine, 2011, Autophagy in immunity and inflammation, Nature, 469, 323, 10.1038/nature09782

S Fujii, 2012, Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease, OncoImmunology, 1, 630, 10.4161/onci.20297

HZ Yang, 2012, Tlr4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury, Am J Pathol, 180, 275, 10.1016/j.ajpath.2011.09.019

H Liu, 2013, Interleukin 17A inhibits autophagy through activation of PIK3CA to interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial cells, Autophagy, 5, 730, 10.4161/auto.24039

S Katiyar, 2009, Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis, Prim Care Respir J, 18, 57, 10.3132/pcrj.2008.00043

E Donado, 2010, No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: Results from a ‘thorough QT/QTc study’ performed according to ICH guidelines, Br J Clin Pharmacol, 69, 401, 10.1111/j.1365-2125.2009.03599.x